You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

  • Technology appraisal guidance
  • Reference number: TA261
  • Published:  25 July 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015 Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015
24 June 2015
(65.99 Kb 19 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 22 June 2015

Back to top